ABSTRACT
The effect of homogeneous fibrin (Fb), collagen (Coll) and composite fibrin-heparin (Fb-Hp), fibrin-collagen (Fb-Coll) membranes on in vitro release of platelet-derived growth factor (PDGF-BB) was evaluated in the presence or absence of amoxicillin using of the ELISA immunoassay test. Amoxicillin concentration was determined spectrophotometrically at 272 nm. The process of the PDGF-BB growth factor and amoxicillin release from the studied membranes was of a two-phase nature in the majority of the systems analysed. The PDGF-BB was released in the highest amount from the Coll membrane (M7) without the presence of amoxicillin – 546.2 ±7.47 pg, t0.5 = 0.88 h and 202.5 ± 6.83 pg, t0.5 = 26.65 h during the first phase and second phase, respectively. The lowest PDGF-BB release was observed from composite M4 (Fb-Hp) membrane – 5.88 ± 0.81 pg, t0.5 = 1.69 h; and 110.2 ± 6.48 pg, t0.5 = 855.6 h during first and second phase respectively. An optimal release of amoxicillin was observed in the case of the composite M6 (Fb-Coll) membrane – only in the second phase: 64.2 ± 7.8 mg, t0.5 = 83.5 h. The lowest and delayed amoxicillin release was achieved for M4 membrane (approx. 17.1 ± 1.12 mg, t0.5 = 46.5 h). The results of the PDGF-BB release and amoxicillin from membranes indicated a correlation between the level of release and composition of the film. Our results suggested that fibrin and collagen membranes may be beneficial to enhance periodontal bone regeneration.
Subject(s)
Amoxicillin/analysis , Amoxicillin/chemistry , Collagen/analysis , Collagen/chemistry , Enzyme-Linked Immunosorbent Assay , Fibrin/analysis , Fibrin/chemistry , Platelet-Derived Growth Factor/chemistry , Proto-Oncogene Proteins c-sis/chemistryABSTRACT
O objetivo foi avaliar a eficácia da amoxicilina em diferentes periodos (3 e 7 dias) no tratamento coadjuvante de abscessos dentoalveolares após realização de drenagem. Foram avaliados 20 voluntários divididos em 2 grupos (n=10): G1 - 19 de amoxicilina, antes do procedimento de drenagem e 500mg de 8/8h por 3 dias; G2 - 1 9 de amoxicilina antes do procedimento e 500mg de 8/8h por 7 dias. Foram avaliados o edema, dor, febre, supuração e trismo, e os voluntários tiveram acompanhamento clínico diário. O edema foi avaliado em duas medidas (Tragus a Asa do Nariz e Tragus a Comissura Labial). A abertura bucal e o edema foram avaliados antes da drenagem, 1, 2, 3 e 7 dias após. Para a avaliação de dor foi utilizada a escala analógica visual (EAV) antes e nos intervalos O, 1 h, 2h, 4h, 12h, 1 dia, 2 dias, 3 dias e 1 semana após. Os resultados fora m su bmetidos à a ná I ise estatística (Kruska II-Wa II is), com n ivel de sig n ificâ ncia de 5%. Quanto aos parâmetros clínicos avaliados, não foram observadas diferenças estatisticamente significantes entre os grupos [p>0,05), e nenhum dos voluntários apresentou complicações no período do pós-atendimento. Concluiu-se que, após a intervenção clínica, a eficácia da amoxicilina nos períodos avaliados foi similar na amostra avaliada
The aim of this study was to compare the use of amoxicillin for different time intervals (3 and 7 days) for treatment of acute dentoalveolar abscesses after performing drainage. Twenty volunteers were divided into two groups (n = 10): G 1 - The volunteers received 1 9 of amoxicillin before the drainage procedure, and 500mg of amoxicillin every 8 hours for 3 days; G2 - The volunteers received 19 of amoxicillin before the drainage procedure, and 500mg of amoxicillin every 8 hours for 7 days. For each patient followed-up, acute infectious conditions were investigated, and pain, edema, fever, suppuration and trismus were evaluated. To evaluate pain was used a visual analog scale [VAS) in the intervals O, 1 h, 2h , 4h , 12 h , 1,2 and 3 days and 1 week after the drainage. The results were submmited to statistical analysis [Kruskal - Wallisl. with a significance levei of 5 %. There was no statistically significant difference between the groups considering the parameters evaluated [p>0.05). None of the volunteers had complications in the post clinical care assessed. It was concluded that after clinical intervention, the effectiveness of the use of amoxicillin in periods of 3 and 7 days was similar in the evaluated volunteers
Subject(s)
Humans , Male , Female , Abscess/therapy , Amoxicillin/analysis , Anti-Bacterial Agents/therapeutic useABSTRACT
The amount of amoxicillin in pharmaceutical formulations was determined using spectra of diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS), in association with partial least squares (PLS) regression. The spectra of 24 different samples (17 for the calibration set and 7 for the validation set), which had been registered using a Nicolet Magna 550 spectrophotometer, contained 76.7-94.3 percent of amoxicillin in starch. The PLS models were constructed with auto-scaled or variance-scaled data, and multiplicative scatter correction (MSC). The best model presented R²=0.9936, RMSEC=0.441 and RMSEV=0.790. The analytical method proposed is non-destructive and the cost and time of analysis are very much reduced, allowing for the fast and direct determination of amoxicillin content.
Neste trabalho propõe-se a quantificação de amoxicilina em formulações farmacêuticas empregando espectroscopia por refletância difusa no infravermelho com transformada de Fourier (DRIFTS) e regressão por mínimos quadrados parciais (PLS). Foram coletados em um espectrômetro Nicolet Magna 550 os espectros de 24 amostras (17 para o conjunto de calibração e 7 para o conjunto de validação) contendo de 76,7-94,3 por cento de amoxicilina em amido. Para a construção dos modelos PLS foi empregada a correção do espalhamento de luz (MSC) e os dados foram autoescalados ou escalados pela variância. Foi obtido um excelente modelo para a previsão da amoxicilina o qual apresentou R²=0,9936, RMSEC=0,441 e RMSEV=0,790. O método proposto além de não destrutivo apresenta baixo tempo de análise e baixo custo podendo ser facilmente empregado no controle de qualidade das indústrias farmacêuticas.
Subject(s)
Amoxicillin/analysis , Pharmaceutical Preparations , Spectroscopy, Fourier Transform Infrared/methods , Quality ControlABSTRACT
A simple, sensitive and facile colorimetric method for quantitative determination of amoxicillin, cefadroxil and ceforperazone is developed. The method is based on the formation of blue colored chromogen upon the reaction of the investigated drugs with 2,6-dichloroquinone chlorimide in alkaline medium. The optimal experimental parameters for the color production are selected. Obedience the Beer's law permitted the successful application of the developed method for the assay of investigated drugs in their pharmaceutical dosage forms. The results obtained are compared with the reported method